A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

NCT00476424 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: efavirenz

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]